Showing results (1061-1070 of 4,514) with videos related to

Sort By:
Pageof 452
Future Oncology (London, England)|May 9, 2024
Unraveling noncoding DNA variants and epimutations: a paradigm shift in hereditary cancer researchMaria Baz Ibrahim, James Flanagan, Tony Ibrahim, et al.
Future Oncology (London, England)|November 9, 2023
A study to learn how well tucatinib plus trastuzumab works for treating participants with metastatic colorectal cancer, and how safe it is: a plain language summary of the MOUNTAINEER studyJohn H Strickler, Tanios S Bekaii-Saab
Future Oncology (London, England)|November 8, 2023
Phase II multicenter trial: first-line immunochemotherapy with or without radiotherapy in metastatic esophageal squamous cell cancer (SCR-ESCC-01)Yue Li, Lin Lin, Jun Liu, et al.
Future Oncology (London, England)|October 9, 2023
In-class transition from bortezomib-based therapy to IRd is an effective approach in newly diagnosed multiple myelomaRobert M Rifkin, Caitlin L Costello, Ruemu E Birhiray, et al.
Future Oncology (London, England)|October 18, 2023
Cetuximab every 2 weeks versus standard weekly dosing administration scheduleCarsten Bokemeyer, Fortunato Ciardiello, Olivier Dubreuil, et al.
Future Oncology (London, England)|October 6, 2023
Prognostic significance of the systemic inflammation response index in gastrointestinal malignancy patients: a pooled analysis of 10,091 participantsXian-Wen Liang, Bing Liu, Hai-Jing Yu, et al.
Future Oncology (London, England)|September 27, 2023
Treatment-related gastrointestinal adverse events of nivolumab plus ipilimumab in randomized clinical trials: a systematic review and meta-analysisKe Liu, Yong-Hong Wang, Na Luo, et al.
Future Oncology (London, England)|September 26, 2023
A randomized phase II study comparing preoperative mFOLFOX6 versus FOLFOXIRI for locally advanced colon cancer: JCOG2006Tadayoshi Hashimoto, Satoshi Maruyama, Yasumasa Takii, et al.
Future Oncology (London, England)|September 25, 2023
Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancerDo-Youn Oh, Aiwu Ruth He, Shukui Qin, et al.
Future Oncology (London, England)|September 22, 2023
A multicenter randomized, controlled clinical trial of adjuvant sintilimab for esophageal squamous cell carcinomaHai-Bo Sun, Wen-Qun Xing, Xian-Ben Liu, et al.
Pageof 452